Subsidy Tracker Parent Company Summary

Parent Company Name: 
Pfizer
Ownership Structure: 
publicly traded (ticker symbol PFE)
Headquartered in: 
New York
Industry: 
pharmaceuticals
Subsidy SummarySubsidy ValueNumber of Awards
State/Local$309,946,032181
Federal (grants and allocated tax credits)$54,408,69829
TOTAL$364,354,730210
Loan / Bailout SummaryTotal Face ValueNumber of Awards
State/Local loans, bond financing and venture capital$00
Federal loans, loan guarantees and bailout assistance (not including repayments)$00
TOTAL$00
Time Period for State and Local Awards: 

Earliest year of data: 1992. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2008.

Time Period for Federal Awards: 

FY2000 to the present

Notes: 

Dollar totals do not include awards for which no subsidy value is disclosed.

Associated Names: 

ALPHARMA; ALPHARMA SPECIALTY PHARMA; AMERICAN HOME PROD; ANACOR PHARMACEUTICALS; BIOREXIS; DORAL / PFIZER; EMBREX; FOLDRX PHARMACEUTICALS; GD SEARLE; HOSPIRA; ICAGEN; INNOPHARMA; KING PHARMACEUTICALS LLC; KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT; PARKE DAVIS; PARKEDALE PHARMACEUTICALS; PFIZER; PFIZER HOLDING AMERICAS; PHARMACIA; SERENEX; UPJOHN; WARNER LAMBERT; WYETH

Links: 

For a summary of this company's regulatory violations see its Violation Tracker summary page here.

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.

For a summary of this company's federal contracts, see its page on Fedspending.

For an overview of political contributions associated with this company, see its Follow the Money page.

For more on the links between this company's federal political spending and its positions on proposed legislation, see its Maplight page.


Top 5 States for state/local awardsTotal Subsidy $Number of Awards
Michigan$84,200,0001
Connecticut$60,000,0001
North Carolina$49,206,93576
New Jersey$38,807,8315
New York$37,829,71022
All other$39,901,55676

Individual Subsidy Records:

Download results as CSV or XML
Company Location Subsidy Source Year Subsidy Valuesort icon Loan/Bailout Value Type of Subsidy
Pfizer Michigan multiple 2001 $84,200,000 MEGADEAL
Pfizer Connecticut multiple 1998 $60,000,000 MEGADEAL
Wyeth Holdings Corporation North Carolina state 2008 $18,128,934 tax credit/rebate
Pharmacia & Upjohn Company New Jersey state 1998 $12,500,000 grant
Pfizer New York local 2003 $10,401,000 tax credit/rebate; property tax abatement
Pfizer Inc. New Jersey state 2010 $9,182,250 grant
Pharmacia Corporation, Affiliates and Subsidiaries New Jersey state 2001 $8,752,000 grant
King Pharmaceuticals, Inc. New Jersey state 2005 $8,253,750 grant
WYETH PHARMACEUTICALS INC United States federal 2003 $7,271,925 federal grant
WYETH PHARMACEUTICALS INC United States federal 2005 $6,364,931 federal grant
WYETH United States federal 2005 $5,636,276 federal grant
Pfizer, Inc. New York local 2007 $5,510,432 tax credit/rebate; property tax abatement
Pfizer, Inc. Pennsylvania state 2011 $5,195,497 tax credit/rebate
WYETH PHARMACEUTICALS INC United States federal 2005 $4,934,072 federal grant
Wyeth Holdings Corporation North Carolina state 2013 $4,097,786 tax credit/rebate
Pfizer, Inc. Pennsylvania state 2010 $4,091,278 tax credit/rebate
PFIZER INC. United States federal 2014 $3,823,709 federal grant
AMERICAN HOME PRODUCTS CORPORATION United States federal 2000 $3,773,578 federal grant
Pfizer, Inc. New York local 2006 $3,750,210 tax credit/rebate; property tax abatement
AMERICAN HOME PRODUCTS CORPORATION United States federal 2004 $3,582,393 federal grant
Wyeth Holdings Corporation North Carolina state 2014 $3,476,438 tax credit/rebate
Pfizer, Inc. New York local 2005 $3,276,473 tax credit/rebate; property tax abatement
AMERICAN HOME PRODUCTS CORPORATION United States federal 2001 $3,247,250 federal grant
PHARMACIA CORPORATION Missouri state 2002 $3,235,374 tax credit/rebate
Doral Arrowwood (Pfizer) New York local 2004 $3,137,110 tax credit/rebate; property tax abatement
Hospira, Inc. and Subsidiaries Illinois state 2005 $3,000,000 grant
WYETH PHARMACEUTICALS INC United States federal 2002 $2,968,632 federal grant
Hospira, Inc. and Subsidiaries Illinois state 2008 $2,872,836 tax credit/rebate
Wyeth Holdings Corporation North Carolina state 2009 $2,868,194 tax credit/rebate
PFIZER INC. United States federal 2014 $2,784,665 federal grant
Pfizer, Inc. Pennsylvania state 2009 $2,715,300 tax credit/rebate
Doral Arrowwood (Pfizer) New York local 2006 $2,022,893 tax credit/rebate; property tax abatement
PFIZER, INC. Missouri state 2007 $2,000,000 training reimbursement
Wyeth Pharmaceuticals Virginia state 2004 $2,000,000 grant
Pfizer, Inc. New York local 2004 $1,919,713 tax credit/rebate; property tax abatement
AMERICAN HOME PRODUCTS CORPORATION United States federal 2002 $1,894,602 federal grant
Hospira, Inc. North Carolina state 2004 $1,812,000 grant
Hospira, Inc. North Carolina state 2010 $1,665,848 tax credit/rebate
Wyeth Holdings Corporation North Carolina state 2009 $1,653,115 tax credit/rebate
Hospira, Inc. North Carolina state 2009 $1,617,030 tax credit/rebate
AMERICAN HOME PRODUCTS CORPORATION United States federal 2003 $1,616,058 federal grant
EMBREX, INC. United States federal 2005 $1,403,707 federal grant
Hospira, Inc. and Subsidiaries Illinois state 2007 $1,385,605 tax credit/rebate
Pfizer, Inc. North Carolina state 2015 $1,320,134 tax credit/rebate
Pfizer Inc. Pennsylvania state 2008 $1,257,546 tax credit/rebate
Hospira, Inc. and Subsidiaries Illinois state 2006 $1,250,000 tax credit/rebate
G.D. SEARLE & COMPANY Missouri state 2002 $1,126,728 tax credit/rebate
Pfizer, Inc. North Carolina state 2016 $1,013,383 tax credit/rebate
Hospira, Inc. and Subsidiaries Illinois state 2005 $1,000,000 tax credit/rebate
Pfizer Inc & Subsidiaries Iowa state 2010 $942,184 tax credit/rebate
Doral/Pfizer New York local 2009 $932,710 tax credit/rebate; property tax abatement
Pfizer, Inc. New York local 2008 $862,541 tax credit/rebate; property tax abatement
Wyeth Pennsylvania state 2008 $802,021 tax credit/rebate
PFIZER INC. United States federal 2014 $787,834 federal grant
Pfizer, Inc. North Carolina state 2013 $755,362 tax credit/rebate
Pfizer, Inc. North Carolina state 2013 $755,362 tax credit/rebate
Doral Arrowwood (Pfizer) New York local 2005 $701,075 tax credit/rebate; property tax abatement
Hospira, Inc. and Subsidiaries Illinois state 2008 $668,300 tax credit/rebate
PFIZER INC. United States federal 2015 $664,225 federal grant
Doral/Pfizer New York local 2007 $662,163 tax credit/rebate; property tax abatement
Hospira inc Kansas state 2013 $650,000 grant
Hospira, Inc. North Carolina state 2015 $623,585 tax credit/rebate
Doral/Pfizer New York local 2003 $613,020 tax credit/rebate; property tax abatement
Pfizer, Inc. North Carolina state 2012 $607,213 tax credit/rebate
Pfizer, Inc. North Carolina state 2012 $607,213 tax credit/rebate
Doral/Pfizer New York local 2014 $607,052 tax credit/rebate
Doral/Pfizer New York local 2010 $596,605 tax credit/rebate; property tax abatement
Hospira, Inc. North Carolina state 2008 $537,281 tax credit/rebate
HOSPIRA, INC. California state 2009 $536,590 training reimbursement
BIOREXIS PHARMACEUTICAL CORPORATION United States federal 2004 $523,510 federal grant
ANACOR PHARMACEUTICALS INC United States federal 2014 $519,843 federal grant
ANACOR PHARMACEUTICALS INC United States federal 2014 $519,575 federal grant
Doral/Pfizer New York local 2013 $516,004 tax credit/rebate; property tax abatement
Pfizer, Inc. North Carolina state 2011 $501,793 tax credit/rebate
Wyeth-Ayerst Pharmaceuticals Pennsylvania state $500,000 grant
Wyeth Pharmaceuticals, Inc. Pennsylvania state $500,000 grant
Wyeth-Lederle (#2) North Carolina state 2004 $500,000 grant
EMBREX United States federal 2005 $494,265 federal grant
Hospira, Inc. North Carolina state 2013 $483,750 grant
Doral/Pfizer New York local 2008 $462,392 tax credit/rebate; property tax abatement
HOSPIRA, INC. California state 2006 $439,595 training reimbursement
Hospira, Inc. North Carolina state 2016 $415,010 tax credit/rebate
Hospira, Inc. and Subsidiaries Illinois state 2007 $404,000 tax credit/rebate
Doral/Pfizer New York local 2015 $402,469 tax credit/rebate
Wyeth Holdings Corporation North Carolina state 2010 $373,801 tax credit/rebate
Doral/Pfizer New York local 2011 $360,540 tax credit/rebate; property tax abatement
Doral/Pfizer New York local 2012 $357,613 tax credit/rebate; property tax abatement
FoldRx Pharmaceuticals Inc. United States federal 2009 $350,000 federal grant
FoldRx Pharmaceuticals, Inc. United States federal 2008 $350,000 federal grant
Hospira, Inc. North Carolina state 2011 $344,981 tax credit/rebate
PFIZER, INC. Missouri state 2000 $315,055 tax credit/rebate
WYETH HOLDINGS CORPORATION New York local 2009 $280,900 tax credit/rebate; property tax abatement
Hospira, Inc. North Carolina state 2016 $277,903 tax credit/rebate
Wyeth Holdings Corporation North Carolina state 2013 $272,967 tax credit/rebate
Wyeth Holdings Corporation North Carolina state 2013 $272,967 tax credit/rebate
EMBREX INC United States federal 2000 $262,125 federal grant
Hospira, Inc. North Carolina state 2013 $261,281 tax credit/rebate
Hospira, Inc. North Carolina state 2008 $254,292 tax credit/rebate
Hospira, Inc. North Carolina state 2011 $252,000 tax credit/rebate
BioRexis Pennsylvania state $250,000 training reimbursement
Hospira, Inc. North Carolina state 2015 $240,137 tax credit/rebate
Download results as CSV or XML